Medical disorders of alcoholism

New England Journal of Medicine

Volumn 333, Issue 16, 1995, Pages 1058-1065

  Flier, Jeffrey S ^a   Underhill, Lisa H ^a   Lieber, Charles Saul ^b  

^a Mount Sinai School of Medicine ^*

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETALDEHYDE; ALCOHOL; ALCOHOL DEHYDROGENASE; BARBITURIC ACID DERIVATIVE; BETA CAROTENE; COLCHICINE; CYTOCHROME P450; METHADONE; OXANDROLONE; PARACETAMOL; PREDNISOLONE; PROPYLTHIOURACIL; RETINOL; S ADENOSYLMETHIONINE; TRANQUILIZER;

ALCOHOL CONSUMPTION; ALCOHOL LIVER CIRRHOSIS; ALCOHOL OXIDATION; ALCOHOLISM; CARCINOGENICITY; CARDIOMYOPATHY; DRUG ALCOHOL INTERACTION; GASTRITIS; HEREDITY; HUMAN; LIVER TRANSPLANTATION; PRIORITY JOURNAL; RETINOL DEFICIENCY; REVIEW;

ADULT; AGED; ALCOHOL DEHYDROGENASE; ALCOHOLISM; CENTRAL NERVOUS SYSTEM DEPRESSANTS; DRUG INTERACTIONS; ETHANOL; FEMALE; HUMAN; LIVER DISEASES, ALCOHOLIC; MALE; METABOLISM; MIDDLE AGE; SEX CHARACTERISTICS; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028810725     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199510193331607     Document Type: Review

References (89)

1. Angell M, Kassirer JP Alcohol and other drugs -- toward a more rational and consistent policy. N Engl J Med 1994; 331: 537-539
2. Adams WL, Yuan Z, Barboriak JJ, Rimm AA Alcohol-related hospitalizations of elderly people. JAMA 1993; 270: 1222-1225 [Erratum, JAMA 1993;270:2055.]
3. Lieber CS, ed. Medical and nutritional complications of alcoholism: mechanisms and management. New York: Plenum Press, 1992.
4. Bureau of Health Statistics and Analysis. Summary of vital statistics, New York. New York: Department of Health, City of New York, 1986.
5. Chedid A, Mendenhall CL, Gartside P, French SW, Chen T, Rabin L Prognostic factors in alcoholic liver disease. Am J Gastroenterol 1991; 86: 210-216
6. Lieber CS Perspectives: do alcohol calories count? Am J Clin Nutr 1991; 54: 976-982
7. Espina N, Lima V, Lieber CS, Garro AJ In vitro and in vivo inhibitory effect of ethanol and acetaldehyde on O6-methylguanine transferase. Carcinogenesis 1988; 9: 761-766
8. Lieber CS, Baraona E, Hernandez-Munoz R, Impaired oxygen utilization: a new mechanism for the hepatotoxicity of ethanol in sub-human primates. J Clin Invest 1989; 83: 1682-1690
9. Wondergem R, Davis J Ethanol increases hepatocyte water volume. Alcohol Clin Exp Res 1994; 18: 1230-1236
10. Hoerner M, Behrens UJ, Worner T, Lieber CS Humoral immune response to acetaldehyde adducts in alcoholic patients. Res Commun Chem Pathol Pharmacol 1986; 54: 3-12
11. Niemela O, Klajner F, Orrego H, Vidins E, Blendis L, Israel Y Antibodies against acetaldehyde-modified protein epitopes in human alcoholics. Hepatology 1987; 7: 1210-1214
12. Garro AJ, McBeth DL, Lima V, Lieber CS Ethanol consumption inhibits fetal DNA methylation in mice: implications for the fetal alcohol syndrome. Alcohol Clin Exp Res 1991; 15: 395-398
13. Abel EL, Sokol RJ A revised conservative estimate of the incidence of FAS and its economic impact. Alcohol Clin Exp Res 1991; 15: 514-524
14. Lieber CS, DeCarli LM Hepatic microsomal ethanol-oxidizing system: in vitro characteristics and adaptive properties in vivo. J Biol Chem 1970; 245: 2505-2512
15. Tsutsumi M, Lasker JM, Shimizu M, Rosman AS, Lieber CS The intralobular distribution of ethanol-inducible P450IIE1 in rat and human liver. Hepatology 1989; 10: 437-446
16. Takahashi T, Lasker JM, Rosman AS, Lieber CS Induction of cytochrome P-4502E1 in the human liver by ethanol is caused by a corresponding increase in encoding messenger RNA. Hepatology 1993; 17: 236-245
17. Sato C, Matsuda Y, Lieber CS Increased hepatotoxicity of acetaminophen after chronic ethanol consumption in the rat. Gastroenterology 1981; 80: 140-148
18. Whitecomb DC, Block GD Association of acetaminophen hepatotoxicity with fasting and ethanol use. JAMA 1994; 272: 1845-1850
19. Hirano T, Kaplowitz N, Tsukamoto H, Kamimura S, Fernandez-Checa JC Hepatic mitochondrial glutathione depletion and progression of experimental alcoholic liver disease in rats. Hepatology 1992; 16: 1423-1427
20. Leo MA, Rosman A, Lieber CS Differential depletion of carotenoids and tocopherol in liver disease. Hepatology 1993; 17: 977-986
21. Garro AJ, Lieber CS Alcohol and cancer. Annu Rev Pharmacol Toxicol 1990; 30: 219-249
22. Leo MA, Lieber CS Hepatic vitamin A depletion in alcoholic liver injury. N Engl J Med 1982; 307: 597-601
23. Leo MA, Lieber CS New pathway for retinol metabolism in liver microsomes. J Biol Chem 1985; 260: 5228-5231
24. Leo MA, Lieber CS Hypervitaminosis A: a liver lover's lament. Hepatology 1988; 8: 412-417
25. Leo MA, Kim CI, Lowe N, Lieber CS Interaction of ethanol with β-carotene: delayed blood clearance and enhanced hepatotoxicity. Hepatology 1992; 15: 883-891
26. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330: 1029-1035
27. Gomberg ESL Women and alcohol: use and abuse. J Nerv Ment Dis 1993; 181: 211-219
28. Frezza M, di Padova C, Pozzato G, Terpin M, Baraona E, Lieber CS High blood alcohol levels in women: the role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. N Engl J Med 1990; 322: 95-99
29. Seitz HK, Egerer G, Simanowski UA, Human gastric alcohol dehydrogenase activity: effect of age, sex, and alcoholism. Gut 1993; 34: 1433-1437
30. Roine R, Gentry RT, Hernandez-Munoz R, Baraona E, Lieber CS Aspirin increases blood alcohol concentrations in humans after ingestion of ethanol. JAMA 1990; 264: 2406-2408
31. Caballeria J, Baraona E, Deulofeu R, Hernandez-Munoz R, Rodes J, Lieber CS Effects of H2-receptor antagonists on gastric alcohol dehydrogenase activity. Dig Dis Sci 1991; 36: 1673-1679
32. Hernandez-Munoz R, Caballeria J, Baraona E, Uppal R, Greenstein R, Lieber CS Human gastric alcohol dehydrogenase: its inhibition by H2-receptor antagonists, and its effect on the bioavailability of ethanol. Alcohol Clin Exp Res 1990; 14: 946-950
33. Palmer RH, Frank WO, Nambi P, Wetherington JD, Fox MJ Effects of various concomitant medications on gastric alcohol dehydrogenase and the first-pass metabolism of ethanol. Am J Gastroenterol 1991; 86: 1749-1755
34. Fraser AG, Hudson M, Sawyerr AM, Rosalki SB, Pounder RE The effect of ranitidine on post-prandial absorption of a low dose of alcohol. Aliment Pharmacol Ther 1992; 6: 267-271
35. DiPadova C, Roine R, Frezza M, Gentry RT, Baraona E, Lieber CS Effects of ranitidine on blood alcohol levels after ethanol ingestion: comparison with other H2-receptor antagonists. JAMA 1992; 267: 83-86 [Erratum, JAMA 1992;268:2652.]
36. Gupta AM, Baraona E, Lieber CS Significant increase of blood alcohol by cimetidine after repetitive drinking of alcohol doses. Alcohol Clin Exp Res 1995; 19: 1083-1087
37. Teschke R, Wiese B Sex-dependency of hepatic alcohol metabolizing enzymes. J Endocrinol Invest 1982; 5: 243-250
38. Maly IP, Sasse D Intraacinar profiles of alcohol dehydrogenase and aldehyde dehydrogenase activities in human liver. Gastroenterology 1991; 101: 1716-1723
39. Morgan MY, Sherlock S Sex-related differences among 100 patients with alcoholic liver disease. BMJ 1977; 1: 939-941
40. Rankin JG. The natural history and management of the patient with alcoholic liver disease. In: Fisher MM, Rankin JG, eds. Alcohol and the liver. Vol. 3 of Hepatology: research and clinical issues. New York: Plenum Press, 1977:365-81.
41. Pequignot G, Chabert C, Eydoux H, Courcoul MA Augmentation du risque de cirrhose en fonction de la ration d'alcool. Rev Alcoolisme 1974; 20: 191-202
42. Parrish KM, Dufour MC, Stinson FS, Harford TC Average daily alcohol consumption during adult life among decedents with and without cirrhosis: the 1986 National Mortality Followback Survey. J Stud Alcohol 1993; 54: 450-456
43. Fukunaga T, Sillanaukee P, Eriksson CJP Occurrence of blood acetaldehyde in women during ethanol intoxication: preliminary findings. Alcohol Clin Exp Res 1993; 17: 1198-1200
44. Lowenfels AB, Zevola SA Alcohol and breast cancer: an overview. Alcohol Clin Exp Res 1989; 13: 109-111
45. Rabinovitz M, Van Thiel DH, Dindzans V, Gavaler JS Endoscopic findings in alcoholic liver disease: does gender make a difference? Alcohol 1989; 6: 465-468
46. Mann K, Batra A, Gunthner A, Schroth G Do women develop alcoholic brain damage more readily than men? Alcohol Clin Exp Res 1992; 16: 1052-1056
47. Department of Agriculture. Dietary guidelines, nutrition and your health: dietary guidelines for Americans. 3rd ed. Washington, D.C.: Government Printing Office, 1990. (Publication no. 1990-273-930.)
48. Potter JF, James OFW Clinical features and prognosis of alcoholic liver disease in respect of advancing age. Gerontology 1987; 33: 380-387
49. Linnoila M, Erwin CW, Ramm D, Cleveland WP Effects of age and alcohol on psychomotor performance of men. J Stud Alcohol 1980; 41: 488-495
50. Lumeng L, Crabb DW Genetic aspects and risk factors in alcoholism and alcoholic liver disease. Gastroenterology 1994; 107: 572-578
51. Kendler KS, Heath AC, Neale MC, Kessler RC, Eaves LJ A population-based twin study of alcoholism in women. JAMA 1992; 268: 1877-1882
52. Blum K, Noble EP, Sheridan PJ, allelic association of human dopamine D2 receptor gene in alcoholism. JAMA 1990; 263: 2055-2060
53. Baraona E, Yokoyama A, Ishii H, Lack of alcohol dehydrogenase isoenzyme activities in the stomach of Japanese subjects. Life Sci 1991; 49: 1929-1934 [Erratum, Life Sci 1993;52:2071.]
54. Worner TM, Lieber CS Perivenular fibrosis as precursor lesion of cirrhosis. JAMA 1985; 254: 627-630
55. Hasumura Y, Minato Y, Nishimura M, Hepatic fibrosis in alcoholics: morphologic characteristics, clinical diagnosis, and natural course. Pathobiol Hepatic Fibrosis 1985; 7: 13-24
56. Lieber CS, Robins SJ, Li J, Phosphatidylcholine protects against fibrosis and cirrhosis in the baboon. Gastroenterology 1994; 106: 152-159
57. Mak KM, Lieber CS Lipocytes and transitional cells in alcoholic liver disease: a morphometric study. Hepatology 1988; 8: 1027-1033
58. Friedman SL The cellular basis of hepatic fibrosis: mechanisms and treatment strategies. N Engl J Med 1993; 328: 1828-1835
59. Moshage H, Casini A, Lieber CS Acetaldehyde selectively stimulates collagen production in cultured rat liver fat-storing cells but not in hepatocytes. Hepatology 1990; 12: 511-518
60. Casini A, Cunningham M, Rojkind M, Lieber CS Acetaldehyde increases procollagen type I and fibronectin gene transcription in cultured rat fat-storing cells through a protein synthesis-dependent mechanism. Hepatology 1991; 13: 758-765
61. Yamada S, Mak KM, Lieber CS Chronic ethanol consumption alters rat liver plasma membranes and potentiates release of alkaline phosphatase. Gastroenterology 1985; 88: 1799-1806
62. Arai M, Gordon ER, Lieber CS Decreased cytochrome oxidase activity in hepatic mitochondria after chronic ethanol consumption and the possible role of decreased cytochrome aa3 content and changes in phospholipids. Biochim Biophys Acta 1984; 797: 320-327
63. Li J-J, Kim C-I, Leo MA, Mak KM, Rojkind M, Lieber CS Polyunsaturated lecithin prevents acetaldehyde-mediated hepatic collagen accumulation by stimulating collagenase activity in cultured lipocytes. Hepatology 1992; 15: 373-381 [Erratum, Hepatology 1993;17:174.]
64. Li J-J, Rosman AS, Leo MA, Nagai Y, Lieber CS Tissue inhibitor of metalloproteinase is increased in the serum of precirrhotic and cirrhotic alcoholic patients and can serve as a marker of fibrosis. Hepatology 1994; 19: 1418-1423
65. McClain C, Hill D, Schmidt J, Diehl AM Cytokines and alcoholic liver disease. Semin Liver Dis 1993; 13: 170-182
66. Paronetto F Immunologic reactions in alcoholic liver disease. Semin Liver Dis 1993; 13: 183-195
67. Rosman AS, Paronetto F, Galvin K, Williams RJ, Lieber CS Hepatitis C virus antibody in alcoholic patients: association with the presence of portal and/or lobular hepatitis. Arch Intern Med 1993; 153: 965-969
68. Lieber CS, Williams R, eds. Recent advances in the treatment of liver disease. In: Drugs. Vol. 40. Suppl. 3. Auckland, New Zealand: Addis International, 1990:1-138.
69. Ramond MJ, Poynard T, Rueff B, A randomized trial of prednisolone in patients with severe alcoholic hepatitis. N Engl J Med 1992; 326: 507-512
70. Mendenhall CL, Anderson S, Garcia-Pont P, Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone. N Engl J Med 1984; 311: 1464-1470
71. Orrego H, Blake JE, Blendis LM, Compton KV, Israel Y Long-term treatment of alcoholic liver disease with propylthiouracil. N Engl J Med 1987; 317: 1421-1427
72. Kershenobich D, Vargas F, Garcia-Tsao G, Tomayo RP, Gent M, Rojkind M Colchicine in the treatment of cirrhosis of the liver. N Engl J Med 1988; 318: 1709-1713
73. Kumar S, Stauber RE, Gavaler JS, Orthotopic liver transplantation for alcoholic liver disease. Hepatology 1990; 11: 159-164
74. Uppal R, Lateef SK, Korsten MA, Paronetto F, Lieber CS Chronic alcoholic gastritis: roles of alcohol and Helicobacter pylori. Arch Intern Med 1991; 151: 760-764
75. Perlow W, Baraona E, Lieber CS Symptomatic intestinal disaccharidase deficiency in alcoholics. Gastroenterology 1977; 72: 680-684
76. Hultberg B, Berglund M, Andersson A, Frank A Elevated plasma homocysteine in alcoholics. Alcohol Clin Exp Res 1993; 17: 687-689
77. Boffetta P, Garfinkel L Alcohol drinking and mortality among men enrolled in an American Cancer Society prospective study. Epidemiology 1990; 1: 342-348
78. Ridker PM, Vaughan DE, Stampfer MJ, Glynn RJ, Hennekens CH Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator. JAMA 1994; 272: 929-933
79. Guivernau M, Baraona E, Lieber CS Acute and chronic effects of ethanol and its metabolites on vascular production of prostacyclin in rats. J Pharmacol Exp Ther 1987; 240: 59-64
80. Renaud S, De Lorgeril M Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992; 339: 1523-1526
81. Gronbaek M, Deis A, Sorensen TIA, Becker U, Schnohr P, Jensen G Mortality associated with moderate intake of wine, beer, or spirits. BMJ 1995; 310: 1165-1169
82. Higuchi S, Muramatsu T, Murayama M, Hayashida M Association of structural polymorphism of the dopamine D2 receptor gene and alcoholism. Biochem Biophys Res Commun 1994; 204: 1199-1205
83. Gejman PV, Ram A, Gelernter J, No structural mutation in the dopamine D2 receptor gene in alcoholism or schizophrenia: analysis using denaturing gradient gel electrophoresis. JAMA 1994; 271: 204-208
84. Day CP, Bashir R, James OF, Investigation of the role of polymorphisms at the alcohol and aldehyde dehydrogenase loci in genetic predisposition to alcohol-related end-organ damage. Hepatology 1991; 14: 798-801 [Erratum, Hepatology 1992;15:750.]
85. Poupon RE, Nalpas B, Coutelle C, Fleury B, Couzigou P, Higueret D Polymorphism of alcohol dehydrogenase, alcohol and aldehyde dehydrogenase activities: implications in alcoholic cirrhosis in white patients. Hepatology 1992; 15: 1017-1022
86. Weiner FR, Eskreis DS, Compton KV, Orrego H, Zern MA Haplotype analysis of a type I collagen gene and its association with alcoholic cirrhosis in man. Mol Aspects Med 1988; 10: 159-168
87. Bashir R, Day CP, James OFW, Ogilvie DJ, Sykes B, Bassendine MF No evidence for involvement of type I collagen structural genes in “genetic predisposition” to alcoholic cirrhosis. J Hepatol 1992; 16: 316-319
88. Sohda T, Shimizu M, Kamimura S, Okumura M Immunohistochemical demonstration of ethanol-inducible P450 2E1 in rat brain. Alcohol Alcohol Suppl 1993; 1: 69-75
89. Laposata AEA, Lange LG Presence of nonoxidative ethanol metabolism in human organs commonly damaged by ethanol abuse. Science 1986; 231: 497-499